
4 min learnNew DelhiJul 26, 2026 10:00 PM IST
Diagnosing Alzheimer’s illness has historically concerned a mix of cognitive assessments, mind scans, and, in some circumstances, invasive spinal fluid checks—an typically prolonged course of that may delay readability for individuals experiencing reminiscence loss and cognitive decline. Now, a easy blood take a look at measuring a protein referred to as p-tau217 is providing recent hope.
Backed by a current JAMA examine and extra findings introduced on the Alzheimer’s Affiliation Worldwide Convention (AAIC), researchers say the take a look at might assist medical doctors establish Alzheimer’s illness earlier and distinguish it from different causes of dementia. Whereas medical doctors warning that it’s not a alternative for standard diagnostic strategies, they imagine it might develop into a worthwhile addition to the diagnostic toolkit, making Alzheimer’s detection sooner, much less invasive, and extra accessible.
DISCLAIMER: This text is predicated on info from the general public area and/or the consultants we spoke to. All the time seek the advice of your well being practitioner earlier than beginning any routine.
What’s the p-tau217 blood take a look at?
Based on Dr Sheetal Goyal, Advisor, Neurologist, Wockhardt Hospitals, Mumbai Central, the p-tau217 blood take a look at detects a protein that rises when the irregular tau modifications related to Alzheimer’s illness start within the mind.
“The p-tau217 blood take a look at measures a protein that will increase when the irregular tau modifications linked to Alzheimer’s illness begin within the mind. It gives a easy and minimally invasive approach to detect the organic modifications associated to the illness,” says Dr Goyal.
Not like cerebrospinal fluid (CSF) evaluation, which requires a lumbar puncture, the blood take a look at entails a routine blood pattern, making it considerably much less invasive and doubtlessly simpler to entry, she provides.
How correct is it?
“Analysis has proven that the p-tau217 take a look at is extremely correct and intently aligns with findings from amyloid PET scans and CSF evaluation,” explains Dr Goyal.
Nonetheless, she emphasises that it shouldn’t be seen as a standalone diagnostic test.
Story continues beneath this advert
“MRI scans stay important for ruling out circumstances resembling stroke, mind tumours, or different neurological issues, whereas cognitive assessments proceed to play a important position in evaluating reminiscence, considering, and total mind operate. At current, the blood take a look at is greatest used to help these present assessments moderately than change them,” she says.
Who ought to contemplate this take a look at?
“The take a look at is principally supposed for individuals with persistent reminiscence issues or different cognitive signs the place Alzheimer’s illness is suspected,” she says.
Individuals who often overlook names or misplace their keys due to stress, insufficient sleep, or regular ageing usually don’t require the take a look at. “It’s not advisable for wholesome people just because they’ve a household historical past of Alzheimer’s. An intensive neurological analysis ought to all the time come first to find out whether or not the blood take a look at is suitable,” Dr Goyal provides.
Can earlier analysis enhance outcomes?
One of many greatest benefits of the p-tau217 take a look at is its potential to establish Alzheimer’s illness earlier, when interventions could also be more practical.
Story continues beneath this advert
“Earlier detection permits sufferers to start therapy sooner, higher handle modifiable danger components, plan for future care, and, the place applicable, access disease-modifying therapies,” says Dr Goyal.
She notes that whereas the take a look at is just not a remedy, earlier analysis can enhance therapy planning and will assist sluggish illness development in eligible sufferers.
What are the present limitations?
“The key challenges embrace standardising the take a look at throughout laboratories, validating its efficiency in numerous populations, guaranteeing affordability, and bettering entry,” Dr Goyal explains.
She is optimistic, nonetheless, about its future in India.
“As analysis continues to develop, these checks are prone to develop into extra extensively obtainable over the subsequent few years, notably at tertiary care centres,” she says.
Story continues beneath this advert
DISCLAIMER: This text is predicated on info from the general public area and/or the consultants we spoke to. All the time seek the advice of your well being practitioner earlier than beginning any routine.




:max_bytes(150000):strip_icc()/HDC-GettyImages-668641904-9179dc9fe60446d8b4d8a08fbffcf46d.jpg?w=600&resize=600,400&ssl=1)





Recent Comments